Mazdutide
PRIME
Innovent · Phase 4 · Recruiting · Enrollment 60
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| GLP-1/GCG receptor dual agonist plus lifestyle optimization (GG Group) | n/r | n/r | n/r | n/r | n/r |
| Lifestyle optimization only (LL group) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.